News

Patents have now been issued in Europe, USA, Japan, Australia and Singapore.

Eight million samples from three-generation study will be managed by automated system.

Service offering expected to advance research programs involved with toxicity assessment, high content screening, and cell-cell communication.

Instrument detected beating rhythm and proarrhythmic effects of nine different compounds on a monolayer of cells, providing evidence for the potential of future screening assays.

Select Biosciences, organisers of the Second European Lab Automation (ELA) at the Congress Center Hamburg, Germany from 30th-31st May 2012, is pleased to offer a ‘bring a buddy’ discount on conference registration fees.

Under the terms of the transaction as described below, Cytomedix issued preferred shares valued at $16 million based on a 10-day volume-weighted average price calculated through February 2, 2012.

Scientists at the University of California, San Diego have developed a new method for making scaffolds for culturing tissue in three-dimensional arrangements that mimic those in the body.

Long-term relationship with global contract research and development organization expands to include right-of-first-offer for potential drug rescue candidates.

The company’s decision to join ARM was based on the alignment of its ongoing mission to offer the highest quality products and services to help accelerate the regenerative medicine industry and ARM's support of policy efforts toward safe and reliable cellular products.

Service offering expected to advance research programs involved with toxicity assessment, high content screening, and cell-cell communication.